Geneos Wealth Management’s BNY Mellon US Mid Cap Core Equity ETF BKMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BKMC
SF
Geneos Wealth Management's BKMC Position: Q3 2026 in Review
Geneos Wealth Management increased its BNY Mellon US Mid Cap Core Equity ETF (BKMC) stake by 0.7% in Q3 2026, buying an estimated $54.9K and bringing the position to 194,954 shares worth $7.52M. The position accounts for 0.14% of the portfolio, ranked #153.
Geneos Wealth Management first reported a position in BKMC in Q4 2020 and has held it in 24 quarters since. The position peaked at $7.99M in Q2 2026. 23 funds tracked by Wall St. Rank hold BKMC as of Q3 2026.
- Geneos Wealth Management held 194,954 shares of BNY Mellon US Mid Cap Core Equity ETF worth $7.52M as of Q3 2026.
- Geneos Wealth Management bought 1,358 BNY Mellon US Mid Cap Core Equity ETF shares in Q3 2026, an estimated $54.9K.
- BNY Mellon US Mid Cap Core Equity ETF made up 0.14% of Geneos Wealth Management's portfolio in Q3 2026, its #153 holding.
- Geneos Wealth Management first reported a position in BNY Mellon US Mid Cap Core Equity ETF in Q4 2020 and has held it in 24 quarters since.
- Geneos Wealth Management's BNY Mellon US Mid Cap Core Equity ETF position peaked at $7.99M in Q2 2026.
- 23 funds tracked by Wall St. Rank held BNY Mellon US Mid Cap Core Equity ETF as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.